Current through Register Vol. 43, No. 1, October 31, 2024
Section 540-X-26-.14 - Protocols(1) The Board of Medical Examiners and the Board of Pharmacy shall promulgate standard protocols consistent with the recommendation of the Joint Committee establishing the patient care services that may be rendered under an Agreement.(2) Protocols deviating from the standard protocols shall be submitted to the Joint Committee for recommendation for approval. When evaluating whether to recommend the approval or denial of a non-standard Protocol, the Joint Committee shall consider certain factors, including, but not limited to:(a) The Collaborating Physician's and Collaborating Pharmacist's education, training, experience, and specialty;(b) The Collaborating Physician's and Collaborating Pharmacist's disciplinary history and any licensure restrictions;(c) FDA approved usages and recommendations;(d) Whether a proposed Protocol is within the current standard of care for treatment of the disease or condition specified in the Protocol, including usages known as "off-label," and whether the use is supported by evidence-based research;(e) Whether the proposed Protocol creates an undue risk of harm to patients; and(f) The routine scope of practice and services provided by the Collaborating Physician and Collaborating Pharmacist.(3) After consideration of the factors listed herein, the Joint Committee may recommend approval or denial of a non-standard Protocol in whole or in part.Ala. Admin. Code r. 540-X-26-.14
Adopted by Alabama Administrative Monthly Volume XXXIX, Issue No. 11, August 31, 2021, eff. 4/12/2021.Author: Alabama Board of Medical Examiners
Statutory Authority:Code of Ala. 1975, § 34-24-53; Act 2019-368 (Code of Ala. 1975, § 34-23-77).